Skip to main content
OpenTrials

Clinical trial condition

Demyelinating Autoimmune Diseases, CNS

Explore clinical trials studying Demyelinating Autoimmune Diseases, CNS. Study availability and eligibility vary by location and protocol.

2,728 public trials 404 recruiting studies
Refine in advanced search Browse all conditions

Demyelinating Autoimmune Diseases, CNS trial results

Completed

BENEFIT Extension Study

NCT00544037

Conditions
Autoimmune Diseases, Autoimmune Diseases of the Nervous System, Demyelinating Autoimmune Diseases, CNS, +4 more
Locations
  • Many Locations, Austria
  • Many Locations, Belgium
  • Many Locations, Canada
  • Many Locations, Czechia
View all 18 locations
View Trial Details
Completed

Open-Label Extension Study to Evaluate the Safety, Tolerability and Activity of Oral Fampridine-SR in Patients With Multiple Sclerosis

NCT00654927

Conditions
Autoimmune Diseases, Autoimmune Diseases of the Nervous System, Demyelinating Autoimmune Diseases, CNS, +4 more
Locations
  • Barrow Neurology Clinic, St. Joseph's Hospital and Medical Center Phoenix, Arizona, United States
  • USC, Keck School of Medicine Health Care Consultation Center Los Angeles, California, United States
  • Shepherd Center Atlanta, Georgia, United States
  • University of Chicago Chicago, Illinois, United States
View all 22 locations
View Trial Details
Completed

Open-Label Extension Study to Evaluate the Safety, Tolerability and Activity of Oral Fampridine-SR in Patients With Multiple Sclerosis Who Participated in the MS-F204 Trial

NCT00649792

Conditions
Autoimmune Diseases, Autoimmune Diseases of the Nervous System, Demyelinating Autoimmune Diseases, CNS, +4 more
Locations
  • Barrow Neurology Clinic, St. Joseph's Hospital and Medical Center Phoenix, Arizona, United States
  • HOPE Research Institute Phoenix, Arizona, United States
  • Neurological Associates Fayetteville, Arkansas, United States
  • Alta Bates Summit Medical Center - Research and Education Institute Berkeley, California, United States
View all 42 locations
View Trial Details
Completed

Open-Label Extension Study to Evaluate the Safety, Tolerability and Activity of Oral Fampridine-SR Tablets in Multiple Sclerosis Patients Who Participated in the MS-F203 Trial

NCT00648908

Conditions
Autoimmune Diseases, Autoimmune Diseases of the Nervous System, Demyelinating Autoimmune Diseases, CNS, +4 more
Locations
  • Barrow Neurology Clinic, St. Joseph's Hospital and Medical Center Phoenix, Arizona, United States
  • USC, Keck School of Medicine Health Care Consultation Center Los Angeles, California, United States
  • UC Davis Sacramento, California, United States
  • Shepherd Center Atlanta, Georgia, United States
View all 32 locations
View Trial Details

Related conditions